BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1040 related articles for article (PubMed ID: 18793723)

  • 1. Oral microemulsions of paclitaxel: in situ and pharmacokinetic studies.
    Nornoo AO; Zheng H; Lopes LB; Johnson-Restrepo B; Kannan K; Reed R
    Eur J Pharm Biopharm; 2009 Feb; 71(2):310-7. PubMed ID: 18793723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cremophor-free intravenous microemulsions for paclitaxel I: formulation, cytotoxicity and hemolysis.
    Nornoo AO; Osborne DW; Chow DS
    Int J Pharm; 2008 Feb; 349(1-2):108-16. PubMed ID: 17869459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cremophor-free intravenous microemulsions for paclitaxel II. Stability, in vitro release and pharmacokinetics.
    Nornoo AO; Chow DS
    Int J Pharm; 2008 Feb; 349(1-2):117-23. PubMed ID: 17869458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions.
    Li P; Ghosh A; Wagner RF; Krill S; Joshi YM; Serajuddin AT
    Int J Pharm; 2005 Jan; 288(1):27-34. PubMed ID: 15607255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of water-in-oil microemulsion for oral delivery of earthworm fibrinolytic enzyme.
    Cheng MB; Wang JC; Li YH; Liu XY; Zhang X; Chen DW; Zhou SF; Zhang Q
    J Control Release; 2008 Jul; 129(1):41-8. PubMed ID: 18474405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation.
    Yin YM; Cui FD; Mu CF; Choi MK; Kim JS; Chung SJ; Shim CK; Kim DD
    J Control Release; 2009 Dec; 140(2):86-94. PubMed ID: 19709639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of surfactant/cosurfactant synergism impact on ibuprofen solubilization capacity and drug release characteristics of nonionic microemulsions.
    Djekic L; Primorac M; Filipic S; Agbaba D
    Int J Pharm; 2012 Aug; 433(1-2):25-33. PubMed ID: 22579578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of ibuprofen-loaded microemulsion for improvement of oral bioavailability.
    Hu L; Yang J; Liu W; Li L
    Drug Deliv; 2011 Jan; 18(1):90-5. PubMed ID: 20942639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of cosurfactants and oils on the formation of pharmaceutical microemulsions based on PEG-8 caprylic/capric glycerides.
    Djekic L; Primorac M
    Int J Pharm; 2008 Mar; 352(1-2):231-9. PubMed ID: 18068919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems.
    Balakrishnan P; Lee BJ; Oh DH; Kim JO; Lee YI; Kim DD; Jee JP; Lee YB; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2009 Jun; 374(1-2):66-72. PubMed ID: 19446761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of silymarin and formulation on the oral bioavailability of paclitaxel in rats.
    Park JH; Park JH; Hur HJ; Woo JS; Lee HJ
    Eur J Pharm Sci; 2012 Feb; 45(3):296-301. PubMed ID: 22172604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation of a cosurfactant-free O/W microemulsion using nonionic surfactant mixtures.
    Cho YH; Kim S; Bae EK; Mok CK; Park J
    J Food Sci; 2008 Apr; 73(3):E115-21. PubMed ID: 18387105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients.
    Malingré MM; Schellens JH; Van Tellingen O; Ouwehand M; Bardelmeijer HA; Rosing H; Koopman FJ; Schot ME; Ten Bokkel Huinink WW; Beijnen JH
    Br J Cancer; 2001 Nov; 85(10):1472-7. PubMed ID: 11720431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of microemulsions containing orange oil with water and propylene glycol as hydrophilic components.
    Yotsawimonwat S; Okonoki S; Krauel K; Sirithunyalug J; Sirithunyalug B; Rades T
    Pharmazie; 2006 Nov; 61(11):920-6. PubMed ID: 17152984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation optimization and in situ absorption in rat intestinal tract of quercetin-loaded microemulsion.
    Gao Y; Wang Y; Ma Y; Yu A; Cai F; Shao W; Zhai G
    Colloids Surf B Biointerfaces; 2009 Jul; 71(2):306-14. PubMed ID: 19375897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oil-in-water lecithin-based microemulsions as a potential delivery system for amphotericin B.
    Pestana KC; Formariz TP; Franzini CM; Sarmento VH; Chiavacci LA; Scarpa MV; Egito ES; Oliveira AG
    Colloids Surf B Biointerfaces; 2008 Oct; 66(2):253-9. PubMed ID: 18676122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biocompatible microemulsions of dicephalic aldonamide-type surfactants: formulation, structure and temperature influence.
    Wilk KA; Zielińska K; Hamerska-Dudra A; Jezierski A
    J Colloid Interface Sci; 2009 Jun; 334(1):87-95. PubMed ID: 19383561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and enhancement of oral bioavailability of curcumin using microemulsions vehicle.
    Hu L; Jia Y; Niu F; Jia Z; Yang X; Jiao K
    J Agric Food Chem; 2012 Jul; 60(29):7137-41. PubMed ID: 22587560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel formulation design of O/W microemulsion for improving the gastrointestinal absorption of poorly water soluble compounds.
    Araya H; Tomita M; Hayashi M
    Int J Pharm; 2005 Nov; 305(1-2):61-74. PubMed ID: 16219433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of nobiletin chitosan-based microemulsions in brain following i.v. injection in mice.
    Yao J; Zhou JP; Ping QN; Lu Y; Chen L
    Int J Pharm; 2008 Mar; 352(1-2):256-62. PubMed ID: 18053660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.